Anti-EGFR bioengineered bacterial outer membrane vesicles as targeted immunotherapy candidate in triple-negative breast tumor murine model

Cancer immunotherapy employing checkpoint inhibitors holds great promise across diverse cancers; nonetheless, a substantial proportion of patients (ranging from 55 to 87%) remain unresponsive to this treatment. To amplify therapeutic efficiency, we propose a synergistic therapeutic strategy that ent...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezaei Adriani, Razieh, Mousavi Gargari, Seyed Latif, Bakherad, Hamid, Amani, Jafar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541432/
https://www.ncbi.nlm.nih.gov/pubmed/37775519
http://dx.doi.org/10.1038/s41598-023-43762-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541432/
https://www.ncbi.nlm.nih.gov/pubmed/37775519
http://dx.doi.org/10.1038/s41598-023-43762-y

Ejemplares similares